![](https://d3ilqtpdwi981i.cloudfront.net/NsGjXln7wu609itLQtc-ga5HKNA=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/e9/1f/2c/e91f2c17-0b0d-4cbf-8fe0-a89fd478b98e/file.jpg)
Article
Abstract CT182: Neoadjuvant immuno-radiotherapy (NIRT) in head and neck cancer: Phase I/Ib study of combined PD-1/SBRT prior to surgical resection
Clinical Trials
(2019)
Disciplines
Publication Date
July 1, 2019
DOI
10.1158/1538-7445.AM2019-CT182
Citation Information
Rom Leidner, R. Bryan Bell, Kristina Young, Brendan Curti, et al.. "Abstract CT182: Neoadjuvant immuno-radiotherapy (NIRT) in head and neck cancer: Phase I/Ib study of combined PD-1/SBRT prior to surgical resection" Clinical Trials Vol. 79 (2019) Available at: http://works.bepress.com/brian-piening/22/